Trademark: 85332657
Word
QUILLIVANT
Status Date
Monday, July 29, 2013
Filing Date
Friday, May 27, 2011
Published for Opposition
Tuesday, November 1, 2011
Abandoned Date
Monday, July 29, 2013
5 Oral liquid suspension pharmaceutical preparations for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder; methylphenidate hydrochloride in oral suspension liquid form for the extended relief of central nervous system diseases and disorders and for the treatment of attention deficit hyperactivity disorder
Color is not claimed as a feature of the mark.
The mark consists of the word, "Quillivant" in stylized lettering.
The wording "QUILLIVANT" has no meaning in a foreign language.
Jul 29, 2013
Abandonment Notice Mailed - No Use Statement Filed
Jul 29, 2013
Abandonment - No Use Statement Filed
Jan 18, 2013
Notice Of Approval Of Extension Request E-Mailed
Jan 17, 2013
Extension 2 Granted
Dec 20, 2012
Extension 2 Filed
Dec 20, 2012
Teas Extension Received
Dec 13, 2012
Attorney Revoked And/Or Appointed
Dec 13, 2012
Teas Revoke/Appoint Attorney Received
Jul 21, 2012
Notice Of Approval Of Extension Request E-Mailed
Jul 20, 2012
Extension 1 Granted
Jun 26, 2012
Extension 1 Filed
Jul 20, 2012
Case Assigned To Intent To Use Paralegal
Jun 26, 2012
Teas Extension Received
Dec 27, 2011
Noa E-Mailed - Sou Required From Applicant
Nov 1, 2011
Official Gazette Publication Confirmation E-Mailed
Nov 1, 2011
Published For Opposition
Sep 28, 2011
Law Office Publication Review Completed
Sep 27, 2011
Assigned To Lie
Sep 15, 2011
Approved For Pub - Principal Register
Sep 15, 2011
Examiner's Amendment Entered
Sep 15, 2011
Notification Of Examiners Amendment E-Mailed
Sep 15, 2011
Examiners Amendment E-Mailed
Sep 15, 2011
Examiners Amendment -Written
Sep 14, 2011
Assigned To Examiner
Jun 2, 2011
New Application Office Supplied Data Entered In Tram
May 31, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
